As a board-certified pediatric endocrinologist, Dr. Gallagher has been caring for children and adolescents with diabetes for over two decades. Since 2016, she has served as the inaugural Director of the Robert I. Grossman, MD & Elisabeth J. Cohen, MD Pediatric Diabetes Center at Hassenfeld Children’s Hospital at NYU Langone and is currently Division Chief of the Pediatric Endocrine and Diabetes Department and Medical Director of the Fink Ambulatory Care Center at Hassenfeld Children's Hospital at NYU Langone. We provide family-centered care with a focus on use of diabetes management technology, education, integrated behavioral health services, and continuous quality improvement. We are among the Pediatric Diabetes Centers participating in the Type 1 Diabetes Exchange QI Learning Collaborative, TrialNet, and Pediatric Diabetes Consortium. These networks study the natural history and novel treatments for children and adolescents with diabetes. Previously, Dr. Gallagher spent over 10 years as the Co-Director of Pediatric Diabetes at the Naomi Berrie Diabetes Center at Columbia University Medical Center. Columbia University is where she first served as a Co-Investigator in the NIH TrialNet Pathway to Prevention trial as well as a Co-Investigator in more than ten studies assessing the efficacy of immunomodulatory agents in slowing the decline of beta cell function in subjects diagnosed with, or at risk for, type 1 diabetes. She also served as site personnel in the NIDDK-funded Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study.